Reconsideration of the lifetime limit of 50 rebated TMS sessions
ObjectiveTo make a case for the Medicare benefits schedule (MBS) rule, that depressed patients who benefit from transcranial magnetic stimulation (TMS) have a lifetime limit of 50 treatments, to be reconsidered.ConclusionEvidence proves TMS can produce remission in major depressive disorder/treatment resistant disorder (MDD/TRD) when medication has failed. This is a relapsing disorder, and further treatments are usually required (but are prevented by this limit). We suggest the limit be raised to 70 treatments (2 courses, or similar) per year.
Authors
- Saxby Pridmore (ORCID: https://orcid.org/0000-0002-9170-1798)
- Marzena Rybak
- Yvonne Turnier-Shea
- Gregory M. Peterson
Institutions
- University of Tasmania (AU)
- Hobart Private Hospital (AU)
Publication Details
- Journal
- Australasian Psychiatry
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1177/10398562261431257
- Primary Topic
- Transcranial Magnetic Stimulation Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00